Core Viewpoint - The company has approved the use of idle raised funds and self-owned funds for cash management and entrusted financial management, ensuring the safety of funds and normal project construction [2][4]. Group 1: Cash Management Approval - The company plans to use up to RMB 100 million of idle raised funds and up to RMB 150 million of idle self-owned funds for cash management and entrusted financial management [2]. - The cash management products will be short-term investments with high safety and liquidity, with a maturity not exceeding 12 months [2]. Group 2: Redemption of Cash Management Products - The company has redeemed all principal and earnings from the cash management products as of the announcement date [3]. Group 3: Approval Process - The proposal for cash management was approved by the company's eighth board of directors and the eighth supervisory board meetings [4]. Group 4: Financial Impact - As of the announcement date, the company has a remaining balance of RMB 57 million in idle raised funds for cash management, which is within the authorized limit [9]. - The total remaining balance of self-owned funds used for cash management and entrusted financial management is RMB 114.0084 million, also within the authorized limit [9].
吉林省西点药业科技发展股份有限公司关于使用闲置募集资金进行现金管理到期赎回的公告